The original success of Viagra undeniably revolutionized the pharmaceutical landscape, but placing funds in companies heavily reliant on off-patent versions presents a challenging picture. Despite early returns were impressive, the end of patents and the appearance of less expensive alternatives have diminished market share. Consequently, a thoroug